Journal article
Authors list: Ghofrani, H. A.; Distler, O.; Gerhardt, F.; Gorenflo, M.; Gruenig, E.; Haefell, W. E.; Held, M.; Hoeper, M. M.; Kaehler, C.-M.; Kaemmerer, H.; Klose, H.; Koellner, V.; Kopp, B.; Mebus, S.; Meyer, A.; Miera, O.; Pittrow, D.; Riemekasten, G.; Rosenkranz, S.; Schranz, D.; Voswinckel, R.; Olschewski, H.
Publication year: 2010
Pages: S87-S101
Journal: Deutsche Medizinische Wochenschrift
Volume number: 135
ISSN: 0012-0472
eISSN: 1439-4413
DOI Link: https://doi.org/10.1055/s-0030-1263316
Publisher: Georg Thieme Verlag
Citation Styles
Harvard Citation style: Ghofrani, H., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W., et al. (2010) Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010, Deutsche Medizinische Wochenschrift, 135, pp. S87-S101. https://doi.org/10.1055/s-0030-1263316
APA Citation style: Ghofrani, H., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W., Held, M., Hoeper, M., Kaehler, C., Kaemmerer, H., Klose, H., Koellner, V., Kopp, B., Mebus, S., Meyer, A., Miera, O., Pittrow, D., Riemekasten, G., Rosenkranz, S., ...Olschewski, H. (2010). Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010. Deutsche Medizinische Wochenschrift. 135, S87-S101. https://doi.org/10.1055/s-0030-1263316
Keywords
BOSENTAN THERAPY; CONTROLLED-TRIAL; DOUBLE-BLIND; EISENMENGER-SYNDROME; Endothelin receptor antagonists; EPOPROSTENOL THERAPY; INHALED ILOPROST; Phosphodiesterase type 5 inhibitors; PORTOPULMONARY HYPERTENSION; prostanoids; pulmonary arterial hypertension (PAH); SILDENAFIL; TREPROSTINIL